Literature DB >> 7575631

Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure.

Y Matsumoto1, T Shinzato, I Amano, I Takai, Y Kimura, H Morita, M Miwa, K Nakane, Y Yoshikai, K Maeda.   

Abstract

Chronic renal failure (CRF) is often complicated by lymphopenia, which may be partly responsible for immune deficiency. We hypothesized that lymphopenia in CRF might result from apoptosis of T cells in vivo. To elucidate the involvement of Fas antigen which mediates apoptosis, we analyzed Fas expression on peripheral blood T cells in uremic non-dialyzed (non-HD) patients and hemodialysis (HD) patients. T cells from both uremic groups expressed Fas with higher intensity than control T cells. When two uremic groups were compared, Fas intensity on T cells was significantly higher in non-HD patients than in patients on HD. Moreover, uremic T cells were shown to undergo accelerated apoptosis when cultured in vitro, in correlation with Fas expression. Our results suggest that T cells in CRF may undergo apoptosis by the Fas system and that hemodialysis treatment has beneficial effects in the light of the inhibition of T cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575631     DOI: 10.1006/bbrc.1995.2438

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1.

Authors:  Asada Leelahavanichkul; Yuning Huang; Xuzhen Hu; Hua Zhou; Takayuki Tsuji; Richard Chen; Jeffrey B Kopp; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2011-08-10       Impact factor: 10.612

2.  Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.

Authors:  Hirohito Ichii; Yuichi Masuda; Tania Hassanzadeh; Mateen Saffarian; Sastry Gollapudi; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2012-06-19       Impact factor: 3.754

3.  Changes in lymphocyte function and subsets in dogs with naturally occurring chronic renal failure.

Authors:  Simona Kralova; Lenka Leva; Miroslav Toman
Journal:  Can J Vet Res       Date:  2010-04       Impact factor: 1.310

Review 4.  Effect of uremia on structure and function of immune system.

Authors:  Nosratola D Vaziri; Madeleine V Pahl; Albert Crum; Keith Norris
Journal:  J Ren Nutr       Date:  2012-01       Impact factor: 3.655

5.  Changes in leukocyte subsets: clinical implications for children with chronic renal failure.

Authors:  Judi Nairn; Greg Hodge; Paul Henning
Journal:  Pediatr Nephrol       Date:  2004-12-30       Impact factor: 3.714

Review 6.  Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach.

Authors:  Caroline Lamarche; Ioan-Andrei Iliuta; Thomas Kitzler
Journal:  Can J Kidney Health Dis       Date:  2019-04-29

Review 7.  [Diagnosis of lymphocytopenia].

Authors:  Alice Berezné; Wafaa Bono; Loïc Guillevin; Luc Mouthon
Journal:  Presse Med       Date:  2006-05       Impact factor: 1.228

8.  Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression.

Authors:  Madeleine V Pahl; Sastry Gollapudi; Lili Sepassi; Pavan Gollapudi; Reza Elahimehr; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2009-08-14       Impact factor: 5.992

9.  A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.

Authors:  Elizabeth N da Silva; Alan Baker; Jalila Alshekaili; Krishna Karpe; Matthew C Cook
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

10.  NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates.

Authors:  David DeWolfe; Malika Aid; Kevin McGann; Joshua Ghofrani; Emma Geiger; Catherine Helzer; Shaily Malik; Steve Kleiboeker; Stephanie Jost; Chen Sabrina Tan
Journal:  Front Immunol       Date:  2019-08-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.